Table of contents as filed with the Securities and Exchange Commission on April 8, 2016 Registration No. 333-210291

Notes to the Consolidated Financial Statements

Yüklə 6,05 Mb.

səhifə	57/81
tarix	02.08.2018
ölçüsü	6,05 Mb.
	#66317

1 ... 53 54 55 56 57 58 59 60 ... 81

Year Ended December 31
Note 8. Income Taxes
The Chemours Company Notes to the Consolidated Financial Statements
December 31, 2015 December 31, 2014

Notes to the Consolidated Financial Statements
(Dollars in millions, except per share)

Note 7. Other Income, Net

	Year Ended December 31,
	2015			2014			2013
Leasing, contract services and miscellaneous income		$	25		$	17		$	24
Royalty income (1)			19			28			24
Gain on purchase of equity method investment			—			—			7
(Loss) gain on sale of assets and businesses (2)			(9 )			40			—
Exchange gains (losses), net (3)			19			(66 )			(31 )
Total other income, net		$	54		$	19		$	24

(1)

Royalty income is primarily for technology and trademark licensing.

(2)

In 2015, the Company sold its subsidiary in Sweden for proceeds of $4 that resulted in a loss on sale of $9 in the Fluoroproducts segment. In 2014, the gain of $40 includes gains on sales of businesses of $30 and $4 in the Fluoroproducts and Titanium Technologies segments, respectively. The remaining $6 related to gain on other sale of assets in the Fluoroproducts segment.

(3)

Chemours uses foreign currency forward contracts to offset its net exposure, by currency, related to its non-functional currency-denominated monetary assets and liabilities. See Note 20 for further information. The pre-tax exchange gains are recorded in other income, net and the related tax impact is recorded in provision for income taxes in the Consolidated Statements of Operations. The $19 net exchange gain for the year ended December 31, 2015 includes a gain on derivatives of $42, partially offset by a $23 pre-tax exchange loss on non-functional monetary assets and liabilities as a result of the strengthening of the U.S. dollar against the Mexican peso, euro, Thai baht, Chinese yuan and other currencies. Exchange losses in 2014 and 2013, respectively, were primarily driven by the strengthening of the U.S. dollar versus the Swiss franc and the euro in 2014, and a strengthening of the U.S. dollar versus the Venezuelan bolivar and the Brazilian real in 2013.

Note 8. Income Taxes

	Year Ended December 31,
	2015			2014			2013
Current tax expense:
U.S. federal		$	37 (1)		$	85		$	67
U.S. state and local			1 (1)			13			11
International			62			73			88
Total current tax expense			100			171			166
Deferred tax (benefit) expense:
U.S. federal			(187 )			(20 )			(4 )
U.S. state and local			(14 )			(3 )			(2 )
International			3			1			(8 )
Total deferred tax benefit			(198 )			(22 )			(14 )
Total (benefit from) provision for income taxes		$	(98 )		$	149		$	152

(1)

Recorded pursuant to the tax matters agreement.

F-21

TABLE OF CONTENTS

The Chemours Company

Notes to the Consolidated Financial Statements
(Dollars in millions, except per share)

The significant components of deferred tax assets and liabilities are as follows:

	December 31, 2015			December 31, 2014
Deferred tax assets – noncurrent:
Other assets and other accrued liabilities		$	257		$	188
Tax loss carryforwards			124			36
Total deferred tax assets – noncurrent			381			224
Valuation allowance			—			(36 )
Total deferred tax assets, net			381			188
Deferred tax liabilities – noncurrent:
Goodwill and other intangibles			—			(2 )
Accrued expenses and other liabilities			(7 )			(34 )
Property, plant and equipment			(530 )			(533 )
Inventories and other assets			(31 )			(33 )
Total deferred tax liabilities – noncurrent			(568 )			(602 )
Net deferred tax liability		$	(187 )		$	(414 )

Yüklə 6,05 Mb.

Dostları ilə paylaş:

1 ... 53 54 55 56 57 58 59 60 ... 81

Table of contents as filed with the Securities and Exchange Commission on April 8, 2016 Registration No. 333-210291​

Notes to the Consolidated Financial Statements

Table of contents as filed with the Securities and Exchange Commission on April 8, 2016 Registration No. 333-210291